Please provide your email address to receive an email when new articles are posted on . Use of robot-assisted vs. open radical cystectomy led to a significantly increased number of days alive and out ...

This transcript has been edited for clarity. Cheryl Lee, MD: Welcome to Medscape InDiscussion. I'm Cheryl Lee, and today we'll be discussing a topic that has continued to be controversial. I'm ...

Robot-assisted radical cystectomy with intracorporeal urinary diversion vs open radical cystectomy resulted in a median of 82 vs 80 days alive and out of the hospital within 90 days of surgery. While ...

Patients requiring intraoperative conversion from robotic-assisted radical cystectomy to open surgery have higher 90-day mortality rates and 30-day readmission rates. Intraoperative conversion from ...

In the past decade there has been a rapid expansion of the use of robotic assistance during surgery that involves minimally invasive approaches. In the United Kingdom, robot-assisted radical ...

A phase II study of single agent abraxane as second-line therapy in patients with advanced urothelial carcinoma No significant financial relationships to disclose. This is an ASCO Meeting Abstract ...

Robotic surgery for bladder cancer speeds recovery, reduces pain, and improves quality of life. It also significantly reduces risks such as blood clots and can preserve functions like sexual health.

The benefits of robotic surgery may have a more pronounced effect in octogenarians, according to investigators. Robotic-assisted radical cystectomy (RARC) for bladder cancer is safe and feasible for ...

Urologic malignancies: A comparison of outcomes after index surgery between academic and community hospitals. This is an ASCO Meeting Abstract from the 2019 Genitourinary Cancers Symposium. This ...